These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS, Konarski JZ, Jones M, Paulsson B. J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [Abstract] [Full Text] [Related]
29. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. Hellings JA, Weckbaugh M, Nickel EJ, Cain SE, Zarcone JR, Reese RM, Hall S, Ermer DJ, Tsai LY, Schroeder SR, Cook EH. J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):682-92. PubMed ID: 16190799 [Abstract] [Full Text] [Related]
31. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, Feirsen N, Pepa L, Anagnostou E. Neuropsychopharmacology; 2010 Mar; 35(4):990-8. PubMed ID: 20010551 [Abstract] [Full Text] [Related]
32. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A. Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [Abstract] [Full Text] [Related]
37. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I. J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157 [Abstract] [Full Text] [Related]